snc logo
Filter
Clear Filters
Search by tag (1)
All of
Any of
None of
Sector 
Target Industry 
Core Technology 
Funding Stage 
Founded 
Business Models 
Product Stage 
Employees 
Location 
Status 
Home > Companies

Companies

Tagged as ('degenerative-diseases') Companies

61 Companies 0 In the News 3 Recently Updated

Company Name Description Founded Business Model Employees Funding Stage Raised Sector Classification

There aren’t any companies that match your search
you can try looking for something else.

A-muse logo
A-muse Non-Active
Therapy Optimization Using Music and Technology 2013 B2B2C, B2C 1-10 Revenue Financed Undisclosed
Disabilities
Sensing
Digital Health
Motion
Consumers
Life Sciences & HealthTech
Healthcare
Providers
Healthcare & Life Sciences
Digital Therapeutics
Demographics & Family
Seniors
Avraham Pharmaceuticals logo
Avraham Pharmaceuticals Non-Active
Prevention of Neurodegenerative Disorders 2010 B2B 11-50 C+ $26.2M
Life Sciences & HealthTech
Healthcare & Life Sciences
Biologicals
Life Sciences
Pharmaceuticals
Discovery & Development
Pharma & Biomedicine
BioGenCell logo
BioGenCell
Stem Cell Therapy Platform for Degenerative Diseases 2008 B2B 1-10 Seed $18.35M
Healthcare & Life Sciences
Biologicals
Life Sciences & HealthTech
Providers
Cells
Life Sciences
Healthcare
Pharma & Biomedicine
Discovery & Development
Biotechnology
Patients
Laboratories
Bone Sci Bio logo
Bone Sci Bio
Scaffold and Drug-delivery Platform for Bone Therapy 2016 B2B 1-10 Seed $1M
Healthcare
Medical Devices
Pharma & Biomedicine
Providers
Cells
Implants
Drug Delivery
Life Sciences
Healthcare & Life Sciences
Treatment & Therapeutics
Materials & Substances
Patients
Pharmaceuticals
Biologicals
Life Sciences & HealthTech
BrainQ Technologies logo
BrainQ Technologies
Neurology Therapies Using Brain–Computer Interface Technology 2016 B2B, B2B2C 11-50 B $68.8M
Healthcare & Life Sciences
Machine Learning
Digital Health
Patients
Providers
Artificial Intelligence
Life Sciences & HealthTech
Healthcare
Digital Therapeutics
BrainStorm logo
BrainStorm Public
Autologous Stem Cell Therapeutics for Neurodegenerative Disorders 2000 B2B 11-50 Public $55.23M
Providers
Healthcare & Life Sciences
Biotechnology
Cells
Biologicals
Pharmaceuticals
Patients
Life Sciences & HealthTech
Pharma & Biomedicine
Discovery & Development
Life Sciences
Healthcare
Cell Cure Neurosciences logo
Cell Cure Neurosciences
Cell Therapies for Neural Degenerative Diseases 2005 B2C 11-50 Revenue Financed $21.79M
Biotechnology
Pharma & Biomedicine
Healthcare & Life Sciences
Pharmaceuticals
Biomaterials
Cells
Life Sciences & HealthTech
Biologicals
Healthcare
Life Sciences
Chi2gel logo
Chi2gel Non-Active
Hybrid Hydrogels for Orthopedics and Rheumatology 2008 B2B, B2G 1-10 Revenue Financed $658K
Biotechnology
Healthcare & Life Sciences
Medical Devices
Life Sciences
Materials & Substances
Polymers
Life Sciences & HealthTech
Providers
Healthcare
Treatment & Therapeutics
Cognyxx Pharmaceuticals logo
Cognyxx Pharmaceuticals
Treatment for Cardiovascular and Neurodegenerative Disorders 2018 B2B 1-10 Bootstrapped Undisclosed
Healthcare
Healthcare & Life Sciences
Providers
Life Sciences & HealthTech
Pharma & Biomedicine
Conflu3nce logo
Conflu3nce
Personalized Solution for Detecting Cognitive Health Changes 2016 B2B, B2B2C, B2C 1-10 Pre-Seed $330K
Computer Vision
Artificial Intelligence
Healthcare
Healthcare & Life Sciences
Software
Digital Therapeutics
Platforms & Interfaces
Simulation & Imaging
Patients
Digital Health
Life Sciences & HealthTech
Dance For Life logo
Dance For Life Non-Active
Dance Training Platform to Enhance Mental Acuity 2017 B2B, B2C 1-10 Bootstrapped Undisclosed
Patients
Consumers
Digital Health
Healthcare
Life Sciences & HealthTech
Digital Therapeutics
Demographics & Family
Motion
Machine Learning
Sensing
Artificial Intelligence
Seniors
Healthcare & Life Sciences
Discure Technologies logo
Discure Technologies
Reversing Degenerative Disc Disease 2021 B2C 1-10 Seed Undisclosed
Patients
Providers
Life Sciences & HealthTech
Treatment & Therapeutics
Medical Devices
Healthcare & Life Sciences
Healthcare
Do4Brain logo
Do4Brain
Cognitive Training for Seniors 2015 B2B2C, B2C 1-10 Revenue Financed Undisclosed
Consumers
Mobile
Seniors
Digital Health
Demographics & Family
Life Sciences & HealthTech
Digital Therapeutics
Platforms & Interfaces
Ela Pharma logo
Ela Pharma
Necrosis Inhibition Technology 2015 B2B 1-10 Seed $77K
Pharmaceuticals
Healthcare & Life Sciences
Biotechnology
Discovery & Development
Pharma & Biomedicine
Life Sciences
Molecules
Life Sciences & HealthTech
Biologicals
elminda logo
elminda
Measuring Brain Health 2006 B2B2C 11-50 C+ $48.73M
Pharmaceuticals
Providers
Life Sciences & HealthTech
Digital Health
Machine Learning
Healthcare & Life Sciences
Life Sciences
Healthcare
Software
Decision Support
Artificial Intelligence
Platforms & Interfaces
Exegiline Pharma logo
Exegiline Pharma
Multifactorial Treatment of Alzheimer's Disease 2020 B2B 1-10 Bootstrapped Undisclosed
Life Sciences & HealthTech
Biologicals
Discovery & Development
Molecules
Life Sciences
Pharma & Biomedicine
Pharmaceuticals
Healthcare & Life Sciences
EyeControl logo
EyeControl
Wearable Assistive Communication Device 2016 B2B, B2B2C, B2C 11-50 A $15.01M
Medical Devices
Software
Semiconductors & Electronics
Wearables
Patients
Machine Learning
Artificial Intelligence
Digital Health
Providers
Healthcare & Life Sciences
Assistive Devices
Communications
Platforms & Interfaces
Computer Vision
Mobile
Healthcare
Assistive Technologies
Life Sciences & HealthTech
GeneFo logo
GeneFo Non-Active
Social Medical Platform for Patients 2014 B2C 1-10 Bootstrapped Undisclosed
Platforms & Interfaces
Digital Health
Web
Life Sciences & HealthTech
Patients
Patient Engagement
Healthcare
Healthcare & Life Sciences
Glixogen Therapeutics logo
Glixogen Therapeutics
Treatment for Enhancing Remyelination in Neurodegenerative Disorders 2018 B2B 1-10 Seed Undisclosed
Biologicals
Healthcare & Life Sciences
Pharmaceuticals
Life Sciences & HealthTech
Pharma & Biomedicine
Life Sciences
Molecules
Discovery & Development
GSKure logo
GSKure
Therapeutic Target for Treating Neurogenetic Disorders 2016 B2B 1-10 Bootstrapped Undisclosed
Pharmaceuticals
Biomaterials
Patients
Healthcare & Life Sciences
Biologicals
Healthcare
Discovery & Development
Pharma & Biomedicine
Life Sciences
Life Sciences & HealthTech
Biotechnology
Headovations logo
Headovations
Head Support Solutions 2010 B2B, B2C 1-10 Revenue Financed Undisclosed
Children
Healthcare & Life Sciences
Life Sciences & HealthTech
Disabilities
Parents
Materials & Substances
Assistive Devices
Demographics & Family
Medical Devices
Providers
Teenagers & Young Adults
Consumers
Healthcare
HelpAround logo
HelpAround
Contextual Patient Support Platform 2013 B2B, B2C 11-50 A $6.55M
Insurance
Software
Digital Health
Mobile
Providers
Healthcare & Life Sciences
Patients
Artificial Intelligence
Patient Engagement
Platforms & Interfaces
Life Sciences & HealthTech
Life Sciences
Healthcare
Pharmaceuticals
ImmunArray logo
ImmunArray Acquired
Diagnostic Tests for Autoimmune Diseases 2006 B2B 1-10 Established $15.5M
Diagnostics
Healthcare
Genes
Providers
Biologicals
Laboratories
Pharma & Biomedicine
Healthcare & Life Sciences
Life Sciences & HealthTech
Immunity Pharma logo
Immunity Pharma
Compounds for Treating Neurodegenerative Diseases 2007 B2B 1-10 Revenue Financed Undisclosed
Pharma & Biomedicine
Healthcare & Life Sciences
Pharmaceuticals
Life Sciences & HealthTech
Cells
Biologicals
Discovery & Development
Life Sciences
Kadimastem logo
Kadimastem Public
Stem Cell Therapeutics for Diabetes and ALS 2008 B2B 11-50 Public $41.3M
Cells
Biomaterials
Healthcare & Life Sciences
Life Sciences & HealthTech
Life Sciences
Pharma & Biomedicine
Discovery & Development
Biologicals
Pharmaceuticals
LuSeed Vascular logo
LuSeed Vascular
Vascular Remodeling Device 2017 B2B 1-10 Seed Undisclosed
Healthcare & Life Sciences
Healthcare
Providers
Medical Devices
Life Sciences & HealthTech
Platforms & Interfaces
Treatment & Therapeutics
Memoria logo
Memoria Non-Active
Intelligent Assistant for Patients with Alzheimer's Disease 2015 B2B2C, B2C 1-10 Seed $16K
Life Sciences & HealthTech
Mobile
Digital Health
IOT
Artificial Intelligence
Patients
Healthcare & Life Sciences
Platforms & Interfaces
Digital Therapeutics
Communications
Healthcare
Providers
miCure Therapeutics logo
miCure Therapeutics
MicroRNA Therapeutics for CNS Disorders 2013 B2B 1-10 Seed $2M
Discovery & Development
Life Sciences & HealthTech
Diagnostics
Life Sciences
Pharmaceuticals
Pharma & Biomedicine
Healthcare & Life Sciences
Biologicals
Biomaterials
Cells
Providers
Healthcare
Mopair Technologies logo
Mopair Technologies
Walking Rehabilitation and Fall Prevention Device 2012 B2B 1-10 Seed $357K
Disabilities
Life Sciences & HealthTech
Healthcare
Medical Devices
Healthcare & Life Sciences
Patients
Machinery & Robotics
Providers
Assistive Devices
Consumers
Demographics & Family
Seniors
MyndYou logo
MyndYou
AI-based Voice Bot for Remote Patient Engagement and Monitoring 2016 B2B 11-50 A $7.9M
Remote Monitoring
Life Sciences & HealthTech
Diagnostics
Healthcare & Life Sciences
Machine Learning
Insurance
Digital Health
Decision Support
Healthcare
Providers
Financial Products
Financial Services
Artificial Intelligence
Patients
Nano Retina logo
Nano Retina
Artificial Retina 2009 B2B 11-50 Revenue Financed $750K
Providers
Treatment & Therapeutics
Materials & Substances
Healthcare
Life Sciences & HealthTech
Nanomaterials
Implants
Healthcare & Life Sciences
Medical Devices
Nayacure Labs logo
Nayacure Labs
Technologies for Restoring the Function of Failing Body Parts 2010 B2B 1-10 Revenue Financed Undisclosed
Biologicals
Cells
Healthcare & Life Sciences
Pharma & Biomedicine
Providers
Life Sciences & HealthTech
Discovery & Development
Healthcare
NeuraLight logo
NeuraLight
AI-driven Platform for Digitizing Neurology 2021 B2B 11-50 A $30.5M
Computer Vision
Diagnostics
Deep Learning
Life Sciences
Pharmaceuticals
Platforms & Interfaces
Providers
Life Sciences & HealthTech
Artificial Intelligence
Healthcare
Digital Health
Healthcare & Life Sciences
Mobile
Neurim Pharmaceuticals logo
Neurim Pharmaceuticals
New Chemical Entities for Insomnia and Alzheimer's Disease 1991 B2B 11-50 Revenue Financed Undisclosed
Life Sciences
Healthcare & Life Sciences
Pharmaceuticals
Discovery & Development
Patients
Life Sciences & HealthTech
Pharma & Biomedicine
Materials & Substances
Biomaterials
Healthcare
Neuromagen Pharma logo
Neuromagen Pharma
Novel Drugs for Neurodegenerative Diseases 2021 B2B 1-10 Seed $500K
Life Sciences & HealthTech
Pharmaceuticals
Pharma & Biomedicine
Discovery & Development
Cells
Biologicals
Life Sciences
Healthcare & Life Sciences
Molecules
NeuroMed logo
NeuroMed Non-Active
Treatment for Neurological Degenerative Diseases 2005 B2B 1-10 Seed $1M
Life Sciences & HealthTech
Healthcare & Life Sciences
Discovery & Development
Pharma & Biomedicine
Life Sciences
Cells
Pharmaceuticals
Biologicals
Neuronix logo
Neuronix Non-Active
Magnetic Stimulation Technology for Alzheimer's Disease 2008 B2B 11-50 Revenue Financed $17.5M
Medical Devices
Life Sciences & HealthTech
Providers
Healthcare & Life Sciences
Healthcare
Treatment & Therapeutics
NeuroPet logo
NeuroPet
Brain Activity System for Monitoring Pets' Emotions and Behavior 2019 B2B, B2B2C 1-10 Bootstrapped Undisclosed
Healthcare & Life Sciences
AgriFood-tech & Water
Healthcare
Cloud
Sensing
Remote Monitoring
Machine Learning
Online Retailers
Data Storage
Recreational & Lifestyle
Digital Health
Pet Owners
Professionals & Gig Economy
Consumers
Artificial Intelligence
Providers
Life Sciences & HealthTech
NeuroQuest logo
NeuroQuest
Immuno-based Blood Tests for Early Detection of Alzheimer's Disease 2008 B2B 11-50 A $500K
Life Sciences
Consumers
Healthcare & Life Sciences
Demographics & Family
Biologicals
Healthcare
Pharma & Biomedicine
Pharmaceuticals
Providers
Diagnostics
Laboratories
Life Sciences & HealthTech
Seniors
NeuroSense Therapeutics logo
NeuroSense Therapeutics Public
Drug for ALS 2017 B2B 11-50 Public $14.2M
Pharma & Biomedicine
Biologicals
Life Sciences & HealthTech
Pharmaceuticals
Discovery & Development
Healthcare & Life Sciences
Life Sciences
Nevrox logo
Nevrox
Therapeutic Small Molecule Inhibitor for Treating Neurodegenerative Disorders 2019 B2B 1-10 Seed Undisclosed
Healthcare & Life Sciences
Biologicals
Life Sciences & HealthTech
Life Sciences
Discovery & Development
Molecules
Pharma & Biomedicine
Pharmaceuticals
NINA Medical logo
NINA Medical
Image-guided Noninvasive Surgery Technologies 2019 B2B 1-10 Seed $900K
Decision Support
Digital Health
Simulation & Imaging
Providers
Medical Devices
Healthcare
Treatment & Therapeutics
Medical Devices
Medical Equipment
Healthcare & Life Sciences
Ultrasound
Life Sciences & HealthTech
Notal Vision logo
Notal Vision
In-home Monitoring of Age-related Macular Degeneration 2000 B2B2C 51-200 C+ $94.05M
Data Storage
Seniors
Healthcare & Life Sciences
Consumers
Life Sciences & HealthTech
Digital Health
Artificial Intelligence
Demographics & Family
Providers
Simulation & Imaging
Diagnostics
Healthcare
Cloud
OnTimeBio logo
OnTimeBio Non-Active
Disease Detection and Monitoring 2017 B2B 1-10 Bootstrapped Undisclosed
Life Sciences & HealthTech
Pharmaceuticals
Digital Health
Healthcare
Life Sciences
Healthcare & Life Sciences
Diagnostics
OptoLight Vision logo
OptoLight Vision
Eye Implants for Patients with Retinal Diseases 2006 B2B 1-10 Revenue Financed Undisclosed
Medical Devices
Implants
Providers
Life Sciences & HealthTech
Materials & Substances
Healthcare
Treatment & Therapeutics
Healthcare & Life Sciences
Perlis logo
Perlis Non-Active
Wireless, Remote Patient-monitoring Solution 2010 B2B 11-50 Revenue Financed $55.14K
Seniors
Platforms & Interfaces
Consumers
Demographics & Family
Healthcare
Remote Monitoring
Wireless
Life Sciences & HealthTech
Digital Health
Artificial Intelligence
Communications
Healthcare & Life Sciences
Patients
Software
Providers
Sensing
Machinery & Robotics
Prilenia Neurotherapeutics logo
Prilenia Neurotherapeutics
Treatments for Neurodegenerative and Neurodevelopmental Disorders 2018 B2B 11-50 B $135.5M
Pharma & Biomedicine
Biotechnology
Biologicals
Discovery & Development
Life Sciences & HealthTech
Life Sciences
Pharmaceuticals
Healthcare & Life Sciences
Prize4Life logo
Prize4Life
Mobile App for Monitoring Disease Progression in People with ALS 2007 B2B, B2C 1-10 Revenue Financed $447.2K
Life Sciences & HealthTech
Healthcare & Life Sciences
Providers
Remote Monitoring
Healthcare
Digital Health
Platforms & Interfaces
Mobile
Protekt Therapeutics logo
Protekt Therapeutics
PKR Inhibition for Treating Neurodegenerative Diseases 2014 B2B 1-10 Seed $13.85M
Pharma & Biomedicine
Pharmaceuticals
Patients
Discovery & Development
Life Sciences
Healthcare
Life Sciences & HealthTech
Healthcare & Life Sciences
Biologicals
Regenera Pharma logo
Regenera Pharma Non-Active
Regenerative Therapy for Neuropathies 2008 B2B 1-10 B $24.02M
Biologicals
Life Sciences & HealthTech
Discovery & Development
Pharma & Biomedicine
Life Sciences
Pharmaceuticals
Healthcare & Life Sciences